Abbott International — Net Sales decreased by 2.6% to $6.89B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.3%, from $6.19B to $6.89B. Over 4 years (FY 2021 to FY 2025), International — Net Sales shows relatively stable performance with a 0.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests successful global market penetration or rising international demand, while a decrease may signal competitive pressure, economic headwinds in foreign markets, or adverse currency translation effects.
This metric represents the total revenue generated from the sale of goods and services within geographic markets outside...
Peers in the medical device and diagnostics sector typically report international revenue as a core indicator of global footprint and geographic diversification strategy.
abt_segment_international_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 6.6B | 6.6B | 6.6B | 7B | 6.4B | 6.3B | 5.9B | 5.8B | 6.2B | 6.3B | 6.3B | 6.1B | 6.4B | 6.4B | 6.6B | 6.2B | 6.9B | 7.1B | 7.1B | 6.9B |
| QoQ Change | — | -1.2% | +0.8% | +5.2% | -8.5% | -0.8% | -7.0% | -0.9% | +6.9% | +1.7% | -0.5% | -2.8% | +5.3% | -0.2% | +3.1% | -6.7% | +10.9% | +3.0% | +0.1% | -2.6% |
| YoY Change | — | — | — | — | -4.2% | -3.7% | -11.2% | -16.4% | -2.3% | +0.2% | +7.2% | +5.1% | +3.6% | +1.7% | +5.4% | +1.2% | +6.6% | +9.9% | +6.7% | +11.3% |